Xencor, Inc.

US$35.75As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:XNCRHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 5.31%
Div yield —
ROE (19.88%)
Biotechnology
Beta (5Y) 0.77
PE TTM —
TSR TTM 143.03%
Mkt cap US$2.683B
ROIC (54.72%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$40
12.02%
(94.47%)
Sell 4|4|10|12|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.88
0.93
0.97
0.92
12.76%
16.91%
14.19%
13.32%
Revenue$M
138.0
140.7
143.5
140.3
6.54%
9.24%
6.05%
4.38%
Peers (US$2.683B)
Cap (US$)
PE
2.787B
88.55x
Capital
TTM
5Y
10Y
Leveragex
0.753
(0.262)
(0.206)
EBIT/Intx
0.333
0.271
0.218
Own earn%
126.79
110.71
120.60
Sh yield%
54.90
35.66
35.49
Owners
Insiders/Inst%
6.54
31.42
Short interest%
4.13
SBC / revenue%
1.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
16–21
$1 testx
0.4
Incr. ROIC%
3